SECTION 2. Section 481.1031,
Health and Safety Code, is amended to read as follows:
Sec. 481.1031. PENALTY GROUP
2-A.
Penalty Group 2-A consists of
any material, compound, mixture, or preparation that contains any
quantity of a synthetic chemical substance, including its salts,
isomers, and salts of isomers, listed by name in this section or contained
within the following structural classes defined in this section [compound
that is a cannabinoid receptor agonist and mimics the pharmacological
effect of naturally occurring cannabinoids, including]:
WIN-55,212-2;
Naphthoylindole: any compound [naphthoylindoles] structurally
derived from 3-(1-naphthoyl)indole or 3-(2-naphthoyl)indole by
substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl,
benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the naphthyl [napthyl] ring to
any extent, including:
AM-1220;
AM-2201;
JWH-004;
JWH-007;
JWH-009;
JWH-015;
JWH-016;
JWH-018;
JWH-019;
JWH-020;
JWH-046;
JWH-047;
JWH-048;
JWH-049;
JWH-050;
JWH-073;
JWH-076;
JWH-079;
JWH-080;
JWH-081;
JWH-082;
JWH-083;
JWH-093;
JWH-094;
JWH-095;
JWH-096;
JWH-097;
JWH-098;
JWH-099;
JWH-100;
JWH-116;
JWH-122;
JWH-148;
JWH-149;
JWH-153;
JWH-159;
JWH-164;
JWH-165;
JWH-166;
JWH-180;
JWH-181;
JWH-182;
JWH-189;
JWH-193;
JWH-198;
JWH-200;
JWH-210;
JWH-211;
JWH-212;
JWH-213;
JWH-234;
JWH-235;
JWH-239;
JWH-240;
JWH-241;
JWH-242;
JWH-258;
JWH-259;
JWH-260;
JWH-262;
JWH-267;
JWH-386;
JWH-387;
JWH-394;
JWH-395;
JWH-397;
JWH-398;
JWH-399;
JWH-400;
JWH-412;
JWH-413;
and
JWH-414;
Naphthylmethylindole: any compound [naphthylmethylindones] structurally
derived from 1H-indol-3-yl-(1-naphthyl)methane or
1H-indol-3-yl-(2-naphthyl)methane by substitution at the nitrogen atom
of the indole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the naphthyl ring to any extent, including:
JWH-175;
JWH-184;
JWH-185;
JWH-192;
JWH-194;
JWH-195;
JWH-196;
JWH-197;
and
JWH-199;
Naphthylindolecarboxamide: any compound structurally derived from
N-(naphthalen-1-yl)-1H-indole-3-carboxamide or
N-(naphthalen-2-yl)-1H-indole-3-carboxamide by substitution at the nitrogen
atom of the indole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl or 2-(4-morpholinyl)alkyl,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the naphthyl ring to any extent, including:
MN-24 (Other name: NNEI);
Naphthoylpyrrole: any compound [naphthoylpyrroles] structurally derived from
3-(1-naphthoyl)pyrrole or 3-(2-naphthoyl)pyrrole by substitution at
the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, benzyl,
halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl,
cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not further substituted in the pyrrole ring to any extent,
whether or not substituted in the naphthyl ring to any extent, including:
JWH-030;
JWH-145;
JWH-146;
JWH-147;
JWH-150;
JWH-156;
JWH-243;
JWH-244;
JWH-245;
JWH-246;
JWH-292;
JWH-293;
JWH-307;
JWH-308;
JWH-309;
JWH-346;
JWH-347;
JWH-348;
JWH-363;
JWH-364;
JWH-365;
JWH-366;
JWH-367;
JWH-368;
JWH-369;
JWH-370;
JWH-371;
JWH-372;
JWH-373;
and
JWH-392;
Naphthylmethylindene: any compound [naphthylmethylindenes] structurally
derived from 1-(1-naphthylmethyl)indene or 1-(2-naphthylmethyl)indene
by substitution at the 3-position of the indene ring by alkyl, haloalkyl,
benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not further substituted in the indene ring to any extent,
whether or not substituted in the naphthyl ring to any extent, including:
JWH-171;
JWH-172;
JWH-173;
and
JWH-176;
Phenylacetylindole: any compound [phenylacetylindoles] structurally derived from
3-phenylacetylindole by substitution at the nitrogen atom of the indole
ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl,
alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not further substituted in the indole ring to any extent, whether
or not substituted in the phenyl ring to any extent, including:
[AM-694;
[AM-1241;]
JWH-167;
JWH-203;
JWH-204;
JWH-205;
JWH-206;
JWH-208;
JWH-237;
JWH-248;
JWH-249;
JWH-250;
JWH-251;
JWH-252;
JWH-253;
JWH-302;
JWH-303;
JWH-305;
JWH-306;
JWH-311;
JWH-312;
JWH-313;
JWH-314;
[and]
JWH-315;
and
RCS-8;
Benzoylindole: any compound structurally derived from
3-benzoylindole by substitution at the nitrogen atom of the indole ring
with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
(N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
2-(4-morpholinyl)alkyl, whether or not further substituted in the indole
ring to any extent, whether or not substituted in the phenyl ring to any
extent, including:
AM-630;
AM-679;
AM-694;
AM-1241;
Pravadoline (Other name: WIN 48,098); and
RCS-4;
Adamantoylindole: any compound structurally derived from
3-(1-adamantoyl)indole or 3-(2-adamantoyl)indole by substitution at the
nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl, halobenzyl,
alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl,
or 2-(4-morpholinyl)alkyl, whether or not further substituted in the indole
ring to any extent, whether or not substituted in the adamantyl ring to any
extent, including:
AB-001; and
AM-1248;
Adamantylindolecarboxamide: any compound structurally derived from
N-(adamantan-1-yl)-1H-indole-3-carboxamide or N-(adamantan-2-yl)-1H-indole-3-carboxamide
by substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
(N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
2-(4-morpholinyl)alkyl, whether or not further substituted in the indole
ring to any extent, whether or not substituted in the adamantyl ring to any
extent, including:
APICA; and
STS-135;
Adamantylindazolecarboxamide: any compound structurally derived
from N-(adamantan-1-yl)-1H-indazole-3-carboxamide or
N-(adamantan-2-yl)-1H-indazole-3-carboxamide by substitution at the
1-position nitrogen atom of the indazole ring by alkyl, haloalkyl, benzyl,
halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl,
cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further
substituted in the indazole ring to any extent, whether or not substituted
in the adamantyl ring to any extent, including:
5-Fluoro AKB-48; and
AKB-48;
Aminooxobutylindazolecarboxamide: any compound structurally derived
from N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide by
substitution at the 1-position nitrogen atom of the indazole ring by alkyl,
haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
(N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
2-(4-morpholinyl)alkyl, whether or not further substituted in the indazole
ring to any extent, including:
AB-PINACA; and
AB-FUBINACA;
Tetramethylcyclopropylindole: any compound structurally derived
from 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole by substitution at
the nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl,
cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further
substituted in the indole ring to any extent, whether or not substituted in
the tetramethylcyclopropyl ring to any extent, including:
A-834,735;
A-796,260;
AB-005;
UR-144;
5-Bromo UR-144;
5-Chloro UR-144; and
5-Fluoro UR-144 (Other name: XLR-11);
Tetramethylcyclopropane-thiazole carboxamide: any compound structurally derived from
2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide by
substitution at the nitrogen atom of the thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl,
or 2-(4-morpholinyl)alkyl, whether or not further substituted in the
thiazole ring to any extent, whether or not substituted in the
tetramethylcyclopropyl ring to any extent, including:
A-836,339;
Quinolinylindolecarboxylate: any compound structurally derived from
quinolin-8-yl indole-3-carboxylate by substitution at the nitrogen atom of
the indole ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl,
or 2-(4-morpholinyl)alkyl, whether or not further substituted in the indole
ring to any extent, whether or not substituted in the quinoline ring to any
extent, including:
BB-22;
5-Fluoro PB-22; and
PB-22;
Cyclohexylphenol: any compound [cyclohexylphenols] structurally derived from
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the
phenolic ring by alkyl, haloalkyl,
benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl],
whether or not substituted in the cyclohexyl ring to any extent, including:
CP-55,940;
CP-47,497;
analogues of CP-47,497, including VII, V, VIII, I, II, III, IV, IX, X,
XI, XII, XIII, XV, and XVI;
JWH-337;
JWH-344;
JWH-345;
and
JWH-405;
and
cannabinol
derivatives, except where
contained in marihuana, including tetrahydro derivatives of cannabinol and
3-alkyl homologues of cannabinol or of its tetrahydro derivatives, such as:
Nabilone;
HU-210; and
HU-211[; and
[WIN-55,212-2].
|
SECTION 2. Section 481.1031,
Health and Safety Code, is amended to read as follows:
Sec. 481.1031. PENALTY GROUP
2-A. (a) In this section:
(1) "Core component" is one of the following:
azaindole, benzimidazole, benzothiazole, carbazole, imidazole, indane,
indazole, indene, indole, pyrazole, pyrazolopyridine, pyridine, or pyrrole.
(2) "Group A component" is one of the following:
adamantane, benzene, cycloalkylmethyl, isoquinoline, methylpiperazine,
naphthalene, phenyl, quinoline, tetrahydronaphthalene,
tetramethylcyclopropane, amino oxobutane, amino dimethyl oxobutane, amino
phenyl oxopropane, methyl methoxy oxobutane, methoxy dimethyl oxobutane,
methoxy phenyl oxopropane, or an amino acid.
(3) "Link component" is one of the following functional
groups: carboxamide, carboxylate, hydrazide, methanone (ketone), ethanone,
methanediyl (methylene bridge), or methine.
(b) Penalty Group 2-A
consists of any material, compound, mixture, or preparation that
contains any quantity of a natural
or synthetic chemical substance,
including its salts, isomers, and salts of isomers, listed by name in this subsection
or contained within one of the structural classes defined in this subsection:
(1) WIN-55,212-2;
(2) Cyclohexylphenol: any
compound [that is a cannabinoid receptor agonist and mimics the
pharmacological effect of naturally occurring cannabinoids, including:
[naphthoylindoles structurally derived from 3-(1-naphthoyl)indole
by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or
not further substituted in the indole ring to any extent, whether or not
substituted in the napthyl ring to any extent, including:
[AM-2201;
[JWH-004;
[JWH-007;
[JWH-009;
[JWH-015;
[JWH-016;
[JWH-018;
[JWH-019;
[JWH-020;
[JWH-046;
[JWH-047;
[JWH-048;
[JWH-049;
[JWH-050;
[JWH-073;
[JWH-076;
[JWH-079;
[JWH-080;
[JWH-081;
[JWH-082;
[JWH-083;
[JWH-093;
[JWH-094;
[JWH-095;
[JWH-096;
[JWH-097;
[JWH-098;
[JWH-099;
[JWH-100;
[JWH-116;
[JWH-122;
[JWH-148;
[JWH-149;
[JWH-153;
[JWH-159;
[JWH-164;
[JWH-165;
[JWH-166;
[JWH-180;
[JWH-181;
[JWH-182;
[JWH-189;
[JWH-193;
[JWH-198;
[JWH-200;
[JWH-210;
[JWH-211;
[JWH-212;
[JWH-213;
[JWH-234;
[JWH-235;
[JWH-239;
[JWH-240;
[JWH-241;
[JWH-242;
[JWH-258;
[JWH-259;
[JWH-260;
[JWH-262;
[JWH-267;
[JWH-386;
[JWH-387;
[JWH-394;
[JWH-395;
[JWH-397;
[JWH-398;
[JWH-399;
[JWH-400;
[JWH-412;
[JWH-413;
and
[JWH-414;
[naphthylmethylindones
structurally derived from 1H-indol-3-yl-(1-naphthyl)methane by substitution
at the nitrogen atom of the indole ring by alkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or
not further substituted in the indole ring to any extent, whether or not
substituted in the naphthyl ring to any extent, including:
[JWH-175;
[JWH-184;
[JWH-185;
[JWH-192;
[JWH-194;
[JWH-195;
[JWH-196;
[JWH-197;
and
[JWH-199;
[naphthoylpyrroles
structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the
nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
substituted in the pyrrole ring to any extent, whether or not substituted
in the naphthyl ring to any extent, including:
[JWH-030;
[JWH-145;
[JWH-146;
[JWH-147;
[JWH-150;
[JWH-156;
[JWH-243;
[JWH-244;
[JWH-245;
[JWH-246;
[JWH-292;
[JWH-293;
[JWH-307;
[JWH-308;
[JWH-309;
[JWH-346;
[JWH-347;
[JWH-348;
[JWH-363;
[JWH-364;
[JWH-365;
[JWH-366;
[JWH-367;
[JWH-368;
[JWH-369;
[JWH-370;
[JWH-371;
[JWH-372;
[JWH-373;
and
[JWH-392;
[naphthylmethylindenes
structurally derived from 1-(1-naphthylmethyl)indene by substitution at the
3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
substituted in the indene ring to any extent, whether or not substituted in
the naphthyl ring to any extent, including:
[JWH-171;
[JWH-172;
[JWH-173;
and
[JWH-176;
[phenylacetylindoles
structurally derived from 3-phenylacetylindole by substitution at the
nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
substituted in the indole ring to any extent, whether or not substituted in
the phenyl ring to any extent, including:
[AM-694;
[AM-1241;
[JWH-167;
[JWH-203;
[JWH-204;
[JWH-205;
[JWH-206;
[JWH-208;
[JWH-237;
[JWH-248;
[JWH-249;
[JWH-250;
[JWH-251;
[JWH-252;
[JWH-253;
[JWH-302;
[JWH-303;
[JWH-305;
[JWH-306;
[JWH-311;
[JWH-312;
[JWH-313;
[JWH-314;
and
[JWH-315;
[cyclohexylphenols]
structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at
the 5-position of the phenolic ring [by
alkyl], (N-methylpiperidin-2-yl)alkyl,
(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [alkenyl, cycloalkylmethyl, cycloalkylethyl,
or 2-(4-morpholinyl)ethyl], whether or not substituted in
the cyclohexyl ring to any extent, including:
JWH-337;
JWH-344;
CP-55,940;
CP-47,497; and
analogues of CP-47,497;
(3) Cannabinol[, including VII, V, VIII, I, II, III, IV, IX,
X, XI, XII, XIII, XV, and XVI;
[JWH-337;
[JWH-344;
[JWH-345;
and
[JWH-405;
and
[cannabinol] derivatives,
except where contained in marihuana, including tetrahydro derivatives of
cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro
derivatives, such as:
Nabilone;
HU-210; and
HU-211;
(4) Tetramethylcyclopropyl thiazole: any
compound structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-
2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of
the thiazole ring, whether or not further substituted in the thiazole ring to any extent, whether or not substituted
in the tetramethylcyclopropyl ring to any extent, including:
A-836,339;
(5) any compound containing a core component substituted at the
1-position to any extent, and substituted at the 3-position with a link
component attached to a group A component, whether or not the core
component or group A component are further substituted to any extent,
including:
Naphthoylindane;
Naphthoylindazole (THJ-018);
Naphthyl methyl indene (JWH-171);
Naphthoylindole (JWH-018);
Quinolinoyl pyrazole carboxylate (Quinolinyl fluoropentyl fluorophenyl
pyrazole carboxylate);
Naphthoyl pyrazolopyridine; and
Naphthoylpyrrole (JWH-030);
(6) any compound containing a core component substituted at the
1-position to any extent, and substituted at the 2-position with a link
component attached to a group A component, whether or not the core
component or group A component are further substituted to any extent,
including:
Naphthoylbenzimidazole (JWH-018 Benzimidazole); and
Naphthoylimidazole;
(7) any compound containing a core component substituted at the
3-position to any extent, and substituted at the 2-position with a link
component attached to a group A component, whether or not the core
component or group A component are further substituted to any extent,
including:
Naphthoyl benzothiazole; and
(8) any compound containing a core component substituted at the
9-position to any extent, and substituted at the 3-position with a link
component attached to a group A component, whether or not the core
component or group A component are further substituted to any extent,
including:
Naphthoylcarbazole (EG-018)
[and
[WIN-55,212-2].
|